Literature DB >> 15877629

Is atrial fibrillation a genetic disease?

Ramon Brugada1.   

Abstract

Atrial fibrillation remains one of the most challenging arrhythmias for the clinician and basic researcher. Different approaches have been undertaken to improve its understanding; from the development of animal models to the analysis of genetic backgrounds in individuals with familial and acquired forms of the disease. In the last few years, a large body of evidence has shown that alterations in ionic currents are involved in the disease. However, it has not been until recently, with the genetic link between mutations in proteins responsible for these ionic currents and the familial disease, that we have been given the final evidence that atrial fibrillation can also be primarily an ion channelopathy. Despite the limited prevalence of the inherited diseases, it has been shown before that the knowledge gained in their study will be helpful in dealing with the most common acquired forms of the disease. Therefore, as data keep unraveling, clinicians can expect that soon better therapeutic and preventive options for atrial fibrillation will emerge from basic science.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877629     DOI: 10.1111/j.1540-8167.2005.40703.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  5 in total

Review 1.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

2.  Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation.

Authors:  Ning Li; Valeriy Timofeyev; Dipika Tuteja; Danyan Xu; Ling Lu; Qian Zhang; Zhao Zhang; Anil Singapuri; Trevine R Albert; Amutha V Rajagopal; Chris T Bond; Muthu Periasamy; John Adelman; Nipavan Chiamvimonvat
Journal:  J Physiol       Date:  2009-01-12       Impact factor: 5.182

3.  Association between KCNE1 (G38S) genetic polymorphism and non-valvular atrial fibrillation in an Uygur population.

Authors:  Miao Haijun; Zhou Xiaohui; Mao Ting; Wilfried Renner; Palida Abulizi; Tang Baopeng
Journal:  Wien Klin Wochenschr       Date:  2012-11-06       Impact factor: 1.704

4.  Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation.

Authors:  Lasse S Ravn; Yoshiyasu Aizawa; Guido D Pollevick; Jacob Hofman-Bang; Jonathan M Cordeiro; Ulrik Dixen; Gorm Jensen; Yuesheng Wu; Elena Burashnikov; Stig Haunso; Alejandra Guerchicoff; Dan Hu; Jesper H Svendsen; Michael Christiansen; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2008-02-04       Impact factor: 6.343

5.  A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control study.

Authors:  Folkert W Asselbergs; Jason H Moore; Maarten P van den Berg; Eric B Rimm; Rudolf A de Boer; Robin P Dullaart; Gerjan Navis; Wiek H van Gilst
Journal:  BMC Med Genet       Date:  2006-04-19       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.